Search PubMed⌕ Search

Biomedical subjects

S C Ng Tang Fui

Publications and source records attributed to S C Ng Tang Fui.

3 recordsLinked to original sources

The iodine concentration in benign and malignant thyroid nodules measured by X-ray fluorescence.

Iodine concentration was measured by X-ray fluorescence in 48 normal thyroid glands obtained at autopsy and in 91 surgical thyroid specimens with a variety of abnormalities. The iodine concentration in normal thyroids ranged from 0.02 to 3.12 mg/g of tissue with a mean value of 1.03 +/- 0.67 mg/g. The concentrations in pathological specimens were generally lower with the lowest values found in thyroid cancers. Sixteen (76%) of 21 malignant thyroid specimens analysed had undetectable iodine (less than 0.02 mg/g) whereas 22 (96%) of 23 benign nodules had measurable iodine concentrations. The detection of iodine in a thyroid nodule by X-ray fluorescence pre-operatively would significantly decrease the probability of malignancy and the need for surgical excision.

Adult↗

Serum thyroglobulin concentrations and whole-body radioiodine scan in follow-up of differentiated thyroid cancer after thyroid ablation.

Measurement of serum thyroglobulin (Tg) concentrations and whole-body radioiodine scan were performed simultaneously during follow-up of 32 patients with differentiated thyroid cancer who had undergone thyroid ablation by operation and radioiodine. Almost all patients in whom serum Tg was undetectable had normal scans. Concentrations exceeding 50 ng/ml were invariably associated with residual or metastatic tumour uptake in the scan. Out of 21 observations of detectable values below 50 ng/ml, 14 were in patients whose scans showed subclinical or sub-radiological tumour uptake and seven in patients with normal scans. The sensitivity of serum Tg as a tumour marker compared favourably to that of the whole-body scan. A scan is unnecessary when serum Tg is undetectable, but in patients with detectable serum Tg concentrations, particularly if these are below 50 ng/ml, a scan is important to assess and localise tumour uptake of iodine before advising treatmet with iodine-131.

Adenocarcinoma↗

Standard dose 131I therapy for hyperthyroidism caused by autonomously functioning thyroid nodules.

Thirty-one patients with hyperthyroidism shown on scintigram to have autonomously functioning thyroid nodules were treated with a standard dose of 15 milliocuries (mCi) of 131I. Of thirty patients who have been followed up for a least 6 months to over 3 years, all but one patient were euthyroid after a single dose. Repeat scintigram and Thyrotropin Releasing Hormone (TRH) test after therapy confirmed that twenty-five patients were cured of the disease. Only one patient developed hypothyroidism. This simplified standard dose regimen of radioiodine is effective in the treatment of hyperthyroidism caused by autonomously functioning nodules and is not complicated by the high incidence of hypothyroidism that is observed following radioiodine therapy of Graves' disease.

Goiter, Nodular↗